- Home
- FGBI vs STRO Comparison
FGBI vs STRO Comparison
Compare FGBI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGBI
- STRO
- Stock Information
- Founded
- FGBI 1934
- STRO 2003
- Country
- FGBI United States
- STRO United States
- Employees
- FGBI N/A
- STRO N/A
- Industry
- FGBI Savings Institutions
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FGBI Finance
- STRO Health Care
- Exchange
- FGBI Nasdaq
- STRO Nasdaq
- Market Cap
- FGBI 158.1M
- STRO 172.8M
- IPO Year
- FGBI N/A
- STRO 2018
- Fundamental
- Price
- FGBI $11.91
- STRO $1.87
- Analyst Decision
- FGBI
- STRO Strong Buy
- Analyst Count
- FGBI 0
- STRO 7
- Target Price
- FGBI N/A
- STRO $12.14
- AVG Volume (30 Days)
- FGBI 12.1K
- STRO 1.5M
- Earning Date
- FGBI 02-03-2025
- STRO 11-13-2024
- Dividend Yield
- FGBI 4.66%
- STRO N/A
- EPS Growth
- FGBI N/A
- STRO N/A
- EPS
- FGBI 0.85
- STRO N/A
- Revenue
- FGBI $95,480,000.00
- STRO $160,955,000.00
- Revenue This Year
- FGBI N/A
- STRO N/A
- Revenue Next Year
- FGBI N/A
- STRO N/A
- P/E Ratio
- FGBI $14.17
- STRO N/A
- Revenue Growth
- FGBI 0.27
- STRO 230.90
- 52 Week Low
- FGBI $8.39
- STRO $1.70
- 52 Week High
- FGBI $15.25
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- FGBI 38.66
- STRO 25.63
- Support Level
- FGBI $11.63
- STRO $1.70
- Resistance Level
- FGBI $13.06
- STRO $3.01
- Average True Range (ATR)
- FGBI 0.46
- STRO 0.21
- MACD
- FGBI -0.30
- STRO -0.05
- Stochastic Oscillator
- FGBI 11.60
- STRO 11.36
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.